Zimbabwe has declined a substantial American health deal valued at 367 million US dollars (£272m) over five years over Washington's demand for sensitive biological samples.
This move came to light following a official document dated December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official representative has since explained that the United States was demanding access to genetic material for research and commercial purposes but was unwilling to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for more negotiations to secure a deal suitable to both sides so the nation's critical HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision comes after a comparable situation in Kenya, where a high court suspended a similar health funding agreement following concerns were filed about the security of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had managed assistance for the US government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral deals to enhance openness and accountability.
According to statements, Sixteen nations in Africa have so far agreed to these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be accessible to our people if a new health crisis arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending frameworks already set up via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.
"This mechanism is intended to guarantee that when a nation contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome further discussions with our US partners on how future co-operation might be structured in a manner that honours the independence and dignity of each country."
Medical Community Reaction
Medical experts expressed it understood the official position, but recommended that negotiations need to persist given that much of the country's HIV programmes depended on international support.
"If technical issues exist, such as those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," the group commented.
This impasse underscores the continuing debate between receiving vital international aid and protecting a country's data in an ever more interconnected world.